Autoimmunity & Inflammation Program
The Autoimmunity and Inflammation Program includes research into the origins and therapeutic modulation of autoimmune destruction of the islet in Type 1 diabetes and into the role of inflammation in Type 2 diabetes. Research within the program has led to novel insights into the surveillance of islet antigens leading to type 1 diabetes, the central role of the breakdown in T cell tolerance in that immune attack on the islet and the role of the immune system in reducing the response of tissues to insulin, leading to type 2 diabetes.
Autoimmunity & Inflammation Program Members
CENTER MEMBERS ARE REMINDED TO ACKNOWLEDGE DERC CENTER GRANT (P30 DK063720) CONTRIBUTIONS WITH ‘THIS RESEARCH WAS SUPPORTED BY GRANTS X, Y FROM NIH P30 DK063720'.